Modified cDNA factor VIII and its derivatives

Details for Australian Patent Application No. 2003264307 (hide)

Owner Aventis Behring GmbH

Inventors Phillips, Martin; Weimer, Thomas; Hauser, Hans-Peter

Agent Watermark

Pub. Number AU-A-2003264307

Priority 02026835.5 29.11.02 EP

Filing date 27 November 2003

Wipo publication date 17 June 2004

International Classifications

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61P 007/04 Drugs for disorders of the blood or the extracellular fluid

A61K 038/37 Medicinal preparations containing peptides

C07K 014/755 Peptides having more than 20 amino acids

Event Publications

11 December 2003 Complete Application Filed

  Priority application(s): 02026835.5 29.11.02 EP

17 June 2004 Application Open to Public Inspection

  Published as AU-A-2003264307

17 March 2005 Change of Name(s) of Applicant(s), Section 104

  Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH 2004

26 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003264308-Aryl nitrone therapeutics for the treatment of inflammatory bowel disease

2003264306-Check valve